Showing results (61-70 of 638) with videos related to

Sort By:
Pageof 64
Bone Marrow Transplantation|October 1, 1990
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusionF Lo Coco, F Mandelli, D Diverio, et al.
Bone Marrow Transplantation|December 1, 1989
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phaseG Meloni, P De Fabritiis, G Alimena, et al.
Blood|April 15, 1991
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemiaF Lo Coco, G Avvisati, D Diverio, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Cancer Research|February 24, 2001
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemiaF F Ferrara, F Fazi, A Bianchini, et al.
Leukemia|May 17, 2003
Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimenC Girmenia, F Lo Coco, M Breccia, et al.
Leukemia Research|January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.
British Journal of Haematology|May 3, 2000
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemiaE Di Bona, G Avvisati, G Castaman, et al.
British Journal of Haematology|August 1, 1991
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotypeF Lo Coco, G Avvisati, D Diverio, et al.
Bone Marrow Transplantation|May 1, 1990
Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, G Alimena, et al.
Pageof 64